Method Comparison of Intelligent Fingerprinting Drug Screening System

Part of paid clinical trials in Marlton, New Jersey.

Sponsor
Intelligent Bio Solutions Inc.
Study ID
NCT07650136
Status
Recruiting
Apply to this trial

Conditions

  • In Vitro Diagnostic Device

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • Diagnostic Test — DEVICE
    Measurement of codeine in human fingerprint sweat

Study Details

Prospective, multi-site, open-label, single- or double-dose, randomized, multi-site performance evaluation of accuracy of the Intelligent Fingerprinting Drug Screening System in the hands of intended users: "operators" and "donors."

Key Dates

Start date
Jun 2, 2026
Status verified
Jun 2026
Primary completion
Jul 31, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
144 participants (estimated)

Arms

  • Arm: Undosed
    No codeine administered
  • Arm: Dosed
    2 doses of codeine administered in tablet form, 60 mg per dose

Primary Outcome Measure

Sensitivity [ Time Frame: 24 hrs ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
CenExel Clinical ResearchMarltonNew Jersey08053
Elan Cohen, PhD

Find similar trials in Marlton, NJ

By research site
CenExel Clinical Research· Marlton, NJ